Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL558 (Dl-mexiletine, Mexiletina, Mexiletine, (rs)-mexiletine) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
Kv11.1/HERG in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL240] [GtoPdb: 572] [UniProtKB: Q12809] | ||||||||
ChEMBL | Inhibition of human ERG | B | 5 | pIC50 | 10000 | nM | IC50 | Eur J Med Chem (2011) 46: 618-630 [PMID:21185626] |
ChEMBL | Inhibition of hERG K channel | F | 5 | pIC50 | >10000 | nM | IC50 | Cardiovasc Res (2011) 91: 53-61 [PMID:21300721] |
K2P3.1/Potassium channel subfamily K member 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2321613] [GtoPdb: 515] [UniProtKB: O14649] | ||||||||
ChEMBL | Inhibition of of TASK1 (unknown origin) expressed in CHO cells assessed as reduction in channel currents | B | 4.01 | pIC50 | 97300 | nM | IC50 | J Med Chem (2016) 59: 5149-5157 [PMID:26588045] |
5-HT2B receptor/Serotonin 2b (5-HT2b) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1833] [GtoPdb: 7] [UniProtKB: P41595] | ||||||||
ChEMBL | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) | B | 6.14 | pKi | 724 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) | B | 5.94 | pIC50 | 1138 | nM | IC50 | DrugMatrix in vitro pharmacology data |
Nav1.2/Sodium channel protein type II alpha subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4187] [GtoPdb: 579] [UniProtKB: Q99250] | ||||||||
ChEMBL | Inhibition of human recombinant Nav1.2 channel expressed in HEK293 cells by whole cell voltage clamp technique | B | 5.54 | pIC50 | 2900 | nM | IC50 | Bioorg Med Chem (2008) 16: 6379-6386 [PMID:18501613] |
Nav1.7/Sodium channel protein type IX alpha subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4296] [GtoPdb: 584] [UniProtKB: Q15858] | ||||||||
ChEMBL | Binding affinity to inactivated human sodium channel Nav1.7 expressed in human HEK293 cells by patch-clamp electrophysiological assay | B | 4.89 | pKi | 13000 | nM | Ki | J Med Chem (2011) 54: 4427-4445 [PMID:21634377] |
ChEMBL | Antagonist activity at 20% inactivated human sodium channel Nav1.7 expressed in human HEK293 cells by patch-clamp electrophysiological assay | F | 1.25 | pIC50 | 56000000 | nM | IC50 | Bioorg Med Chem Lett (2012) 22: 1055-1060 [PMID:22209205] |
ChEMBL | Inhibition of 20% inactivated human sodium channel Nav1.7 expressed in human HEK293 cells by patch-clamp electrophysiological assay | B | 4.25 | pIC50 | 56000 | nM | IC50 | J Med Chem (2011) 54: 4427-4445 [PMID:21634377] |
ChEMBL | Blockade of human Nav1.7 channel expressed in HEK293 cells by FRET assay | B | 4.96 | pIC50 | 11000 | nM | IC50 | Bioorg Med Chem Lett (2008) 18: 1696-1701 [PMID:18243692] |
ChEMBL | Inhibition of human Nav1.7 in inactivated condition by automated patch-clamp assay | B | 5.13 | pIC50 | 7400 | nM | IC50 | RSC Med Chem (2022) 13: 895-920 [PMID:36092147] |
Nav1.5/Sodium channel protein type V alpha subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1980] [GtoPdb: 582] [UniProtKB: Q14524] | ||||||||
ChEMBL | Blockade of human full-length NaV1.5 expressed in HEK293 cells co-transfected with pCD8-IRES-hbeta1 assessed as 10 Hz of use-dependent-induced channel current at -120 mV holding potential after 36 to 72 hrs by patch clamp assay | B | 4.24 | pIC50 | 58000 | nM | IC50 | J Med Chem (2012) 55: 1418-1422 [PMID:22191686] |
ChEMBL | Inhibition of human Nav1.5 in inactivated condition by automated patch-clamp assay | B | 4.82 | pIC50 | 15000 | nM | IC50 | RSC Med Chem (2022) 13: 895-920 [PMID:36092147] |
ChEMBL | Inhibition of human recombinant Nav1.5 channel expressed in HEK293 cells by whole cell voltage clamp technique | B | 4.89 | pIC50 | 13000 | nM | IC50 | Bioorg Med Chem (2008) 16: 6379-6386 [PMID:18501613] |
ChEMBL | Inhibition of Nav1.5 (unknown origin)-mediated late channel current | B | 5.52 | pIC50 | 3000 | nM | IC50 | Bioorg Med Chem Lett (2021) 45: 128133-128133 [PMID:34044121] |
Nav1.8/Sodium channel protein type X alpha subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5451] [GtoPdb: 585] [UniProtKB: Q9Y5Y9] | ||||||||
ChEMBL | Inhibition of human recombinant Nav1.8 channel expressed in HEK293 cells by whole cell voltage clamp technique | B | 4.25 | pIC50 | 56000 | nM | IC50 | Bioorg Med Chem (2008) 16: 6379-6386 [PMID:18501613] |
Nav1.8/Sodium channel protein type X alpha subunit in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4017] [GtoPdb: 585] [UniProtKB: Q62968] | ||||||||
ChEMBL | Blockade of Nav1.8 channel in rat dorsal root ganglion neurons assessed as inhibition of TTX-R current by whole cell patch clamp technique | B | 4.51 | pIC50 | 31000 | nM | IC50 | Bioorg Med Chem (2008) 16: 6379-6386 [PMID:18501613] |
ChEMBL | Inhibition of Nav1.8 channel in rat dorsal root ganglion neurons assessed as blockade of TTX-R current by patch clamp method | B | 4.52 | pIC50 | >30000 | nM | IC50 | Proc Natl Acad Sci U S A (2007) 104: 8520-8525 [PMID:17483457] |
Nav1.4 in Human [GtoPdb: 581] [UniProtKB: P35499] | ||||||||
GtoPdb | - | - | 3.4 | pIC50 | - | - | - | J Physiol (Lond.) (2004) 554: 621-33 [PMID:14608007] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]